- Exchange: NASDAQ GS
- Sector: Health Care
- Industry: Biotech & Pharma
- Sub-Industry: Biotech
Sangamo BioSciences Inc+ Add to Watchlist
SGMO:US14.7000 USD 0.8400 5.41%
As of 20:10:00 ET on 04/24/2015.
Company Profile for Sangamo BioSciences Inc (SGMO)
Sangamo BioSciences, Inc. researches and develops transcription factors in the regulation of genes. These transcription factors are the proteins that turn genes on and off and regulate gene expression by recognizing specific DNA sequences.
Sangamo BioSciences Inc
Key Executives for Sangamo BioSciences Inc (SGMO)
|Edward O Lanphier IIPresident/CEO/Founder||H Ward WolffExec VP/CFO|
|Geoffrey M Nichol "Geoff"Exec VP:Research & Development||Philip D GregoryVP:Research/Chief Scientific Ofcr|
|Dale G AndoVP:Therapeutic Dev/Chief Medical||Elizabeth WolffeInvestor Relations|